This compound is an active pharmaceutical ingredient used in pharmaceutical manufacturing. It is a quinazoline derivative with a complex structure that includes an amide, amine, and ether functional groups.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 2475094-87-0
(S,E)-N-(4-((3,4-Difluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide (Afatinib Impurity)
Afatinib impurity reference standard
(S,E)-N-(4-((3,4-Dichlorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide (Afatinib Impurity)
active pharmaceutical ingredient impurity
Afatinib Impurity 18
Pharmaceutical impurity reference standard
Afatinib D6
active pharmaceutical ingredient
(-)-Epiafzelechin
active pharmaceutical ingredient (API) standard
Prasteronyl Abiraterone
active pharmaceutical ingredient
(3alpha)-3-Acetate-17-(3-pyridinyl)-androsta-5,16-dien-3-ol
Abiraterone acetate impurity
Beta-Epoxyabiraterone acetate
Active pharmaceutical ingredient for cancer
(E)-N-[4-(4-chloro-3-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide
CIGJZGGVLAOLAG-CWDCEQMOSA-N
CN(C)C/C=C/C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)Cl)F)O[C@H]4CCOC4